https://orcid.org/0000-0002-5771-4616
Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zenon Konteatis. (2021) What makes a good fragment in fragment-based drug discovery?. Expert Opinion on Drug Discovery 16:7, pages 723-726.
Read now
Read now
Articles from other publishers (5)
Kyriakos Georgiou, Athina Konstantinidi, Johanna Hutterer, Kathrin Freudenberger, Felix Kolarov, George Lambrinidis, Ioannis Stylianakis, Margarita Stampelou, Günter Gauglitz & Antonios Kolocouris. (2024) Accurate calculation of affinity changes to the close state of influenza A M2 transmembrane domain in response to subtle structural changes of adamantyl amines using free energy perturbation methods in different lipid bilayers. Biochimica et Biophysica Acta (BBA) - Biomembranes 1866:2, pages 184258.
Crossref
Crossref
Blessy M. Suresh, Amirhossein Taghavi, Jessica L. Childs-Disney & Matthew D. Disney. (2023) Fragment-Based Approaches to Identify RNA Binders. Journal of Medicinal Chemistry 66:10, pages 6523-6541.
Crossref
Crossref
Conceição A. Minetti & David P. Remeta. (2022) Forces Driving a Magic Bullet to Its Target: Revisiting the Role of Thermodynamics in Drug Design, Development, and Optimization. Life 12:9, pages 1438.
Crossref
Crossref
Andreas LangerAnnemarie LüdeckeTanja BartoschikOndrej CehlarStefan DuhrPhilipp BaaskeWerner Streicher. (2022) A New Spectral Shift-Based Method to Characterize Molecular Interactions. ASSAY and Drug Development Technologies 20:2, pages 83-94.
Crossref
Crossref
Dávid Bajusz, Warren S. Wade, Grzegorz Satała, Andrzej J. Bojarski, Janez Ilaš, Jessica Ebner, Florian Grebien, Henrietta Papp, Ferenc Jakab, Alice Douangamath, Daren Fearon, Frank von Delft, Marion Schuller, Ivan Ahel, Amanda Wakefield, Sándor Vajda, János Gerencsér, Péter Pallai & György M. Keserű. (2021) Exploring protein hotspots by optimized fragment pharmacophores. Nature Communications 12:1.
Crossref
Crossref